Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Underwritten Public Offering	Private Placement	Common Stock	Common Stock Underwritten Public Offering	Common Stock Private Placement	Additional Paid-in Capital	Additional Paid-in Capital Underwritten Public Offering	Additional Paid-in Capital Private Placement	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2022	$ 949			$ 1			$ 402,389			$ (401,441)
Balance, shares at Dec. 31, 2022				63,207,507
Stock-based compensation	7,905						7,905
Issuance of common stock, Value			$ 103,239			$ 1			$ 103,238
Issuance of common stock, shares						123,117,594
Issuance of common stock upon vesting and settlement of restricted stock units, shares				566,772
Issuance of common stock under ESPP	68						68
Issuance of common stock under ESPP, shares				68,320
Reclassification of pre-funded warrants to equity classification	74,342						74,342
Net loss	(111,566)									(111,566)
Balance at Dec. 31, 2023	$ 74,937			$ 2			587,942			(513,007)
Balance, shares at Dec. 31, 2023	186,960,193			186,960,193
Stock-based compensation	$ 13,103						13,103
Issuance of common stock, Value		$ 76,694						$ 76,694
Issuance of common stock, shares					17,596,113
Issuance of common stock upon vesting and settlement of restricted stock units	(9)						(9)
Issuance of common stock upon vesting and settlement of restricted stock units, shares				234,198
Issuance of common stock under ESPP	89						89
Issuance of common stock under ESPP, shares				93,970
Issuance of common stock upon exercise of stock options	40						40
Issuance of common stock upon exercise of stock options, shares				58,832
Loss on instrument-specific credit risk	(4,031)										$ (4,031)
Net loss	(89,298)									(89,298)
Balance at Dec. 31, 2024	$ 71,525			$ 2			$ 677,859			$ (602,305)	$ (4,031)
Balance, shares at Dec. 31, 2024	204,943,306			204,943,306